Judith M. Matthews
Net Worth
Last updated:
What is Judith M. Matthews net worth?
The estimated net worth of Ms. Judith M. Matthews is at least $4,395,268 as of 11 Mar 2023. She owns shares worth $56,151 as insider, has earned $96,137 from insider trading and has received compensation worth at least $4,242,980 in Iterum Therapeutics plc.
What is the salary of Judith M. Matthews?
Ms. Judith M. Matthews salary is $606,140 per year as Chief Financial Officer in Iterum Therapeutics plc.
How old is Judith M. Matthews?
Ms. Judith M. Matthews is 55 years old, born in 1970.
What stocks does Judith M. Matthews currently own?
As insider, Ms. Judith M. Matthews owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Iterum Therapeutics plc (ITRM) | Chief Financial Officer | 65,292 | $0.86 | $56,151 |
What does Iterum Therapeutics plc do?
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Judith M. Matthews insider trading
Iterum Therapeutics plc
Ms. Judith M. Matthews has made 4 insider trades between 2018-2023, according to the Form 4 filled with the SEC.
The largest trade she's ever made was exercising 100,000 units of ITRM stock on 14 Mar 2022. As of 11 Mar 2023 she still owns at least 65,292 units of ITRM stock.
Iterum Therapeutics key executives
Iterum Therapeutics plc executives and other stock owners filed with the SEC:
- Dr. Michael W. Dunne M.D. (65) Strategic Advisor & Director
- Mr. Corey N. Fishman (60) Pres, Chief Executive Officer & Director
- Ms. Judith M. Matthews (55) Chief Financial Officer